DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Janus kinase 2
Janus kinase 2
Mutation Analysis in Myeloproliferative Neoplasms AHS - M2101
942.Full.Pdf
Anti-Inflammatory Cytokines Hepatocyte Growth Factor and Interleukin-11 Are Over-Expressed in Polycythemia Vera and Contribute T
Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions Khushwant S
Novel Transcripts from a Distinct Promoter That Encode the Full-Length
Targeting Janus Kinase 2 in Her2/Neu-Expressing Mammary Cancer: Implications for Cancer Prevention Andtherapy
Role of the Tyrosine Kinase JAK2 in Signal Transduction by Growth Hormone
Interpretation of Cytokine Signaling Through the Transcription Factors STAT5A and STAT5B
Lung Cancer Biomarkers, Targeted Therapies and Clinical Assays
Janus Kinases in Leukemia
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
Chapter 1: Introduction
NIH Public Access Author Manuscript J Mammary Gland Biol Neoplasia
Epidermal Growth Factor Activates Na+/H+ Exchanger in Podocytes Through a Mechanism That Involves Janus Kinase and Calmodulin
Dual Inhibition of Jak2 and STAT5 Enhances Killing of Myeloproliferative Neoplasia Cells
Janus Kinase 2 Regulates Transcription Factor EB Expression and Autophagy Completion in Glomerular Podocytes
Molecular Network Pathway of ERBB in Diffuse-Type Gastric Cancer
Top View
Convergent and Divergent Cellular Responses by Erbb4 Isoforms in Mammary Epithelial Cells
Insulin and Adipokine Signaling and Their Cross-Regulation in Postmortem Human Brain
DARPP-32 Promotes ERBB3-Mediated Resistance to Molecular Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma
MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer
Integrated in Silico Docking and MOMA Simulation Methods Reveal Rottlerin As a Potent Janus Kinase 2 (JAK2) Inhibitor
Erbb3 Drives Mammary Epithelial Survival and Differentiation During Pregnancy and Lactation Michelle M
JAK2V617F-Positive Myeloproliferative Neoplasms : KI Mouse Models, Interferon-Α Therapy and Clonal Architecture Salma Hasan
JAK2 Inhibitor: in Vitro Assessment of Kinase Selectivity and Preclinical Studies Using Cell Lines and Primary Cells from Polycythemia Vera Patients
Janus Kinase 2 Mutations in Cases with BCR‑ABL‑Negative Chronic Myeloproliferative Disorders from Turkey
JAK: No Longer ‘Just Another Kinase’
Multiscale Modeling of the Erbb Receptor Tyrosine Kinase Signaling Network Through Theory and Experiment
Myeloproliferative Disorders: Premalignant, Stem Cell, G1 Diseases?
Insufficiency of Janus Kinase 2–Autonomous Leptin Receptor
The Role of JAK2 in Myeloproliferative Diseases Diagnosis
Structure of the Pseudokinase–Kinase Domains from Protein Kinase TYK2 Reveals a Mechanism for Janus Kinase (JAK) Autoinhibition
Structure of the Pseudokinase–Kinase Domains from Protein Kinase TYK2 Reveals a Mechanism for Janus Kinase (JAK) Autoinhibition
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
Severe Asthma with Blood Hypereosinophilia Associated with JAK2V617F Mutation: a Case Series
The Janus Kinase 2 (JAK2) V617F Mutation in Chinese Patients With
Human Malignant Mesothelioma Cell Growth: Activation of Janus Kinase 2 and Signal Transducer and Activator of Transcription La for Inhibition by Interferon-Y!
JAK2V617F-Positive Myeloproliferative Neoplasms
Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
Genome Editing to Model and Reverse a Prevalent Mutation Associated with Myeloproliferative
(JAK2) V617F Mutation in Hematological Malignancies in México
A Tumor Suppressor Function for Ptpn1 in Myeloproliferative Neoplasms
JAK2, STAT3 and SOCS3 Gene Expression in Women with and Without Breast Cancer
Janus Kinase 2 Is Required for the Initiation but Not Maintenance of Prolactin-Induced Mammary Cancer
Human Kinase Library II
Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene
JAK/STAT Proteins and Their Biological Impact on NK Cell Development and T Function ⁎ Alexander Vargas-Hernándeza,B, Lisa R
Rethinking JAK2 Inhibition: Towards Novel Strategies of More Specific and Versatile Janus Kinase Inhibition
Identifying the Role of Janus Kinase 1 in Mammary Gland Development and Breast Cancer
Variable IPSS DIPSS DIPSS-Plus
Janus Kinase Inhibitors in Myeloproliferative Neoplasms Clinical Applications
Improved Probes for Detection of V617F Mutation in Chromosome 9-Borne JAK 2 Gene Linked to Conditions of Polycythemia Vera and Other Myeloproliferative Disorders
Janus Kinase Inhibitors Mechanisms of Action